Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 11.05% | -10.74% | -10.74% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 11.05% | -10.74% | -10.74% |
Baron Discovery Fund declined 10.65% in Q1 2026, underperforming the Russell 2000 Growth Index by 7.84%. Software holdings were the primary detractor, contributing 4.36% of negative performance due to AI disruption fears in the so-called SaaS-pocalypse. Despite strong earnings, software companies declined as markets viewed them as AI losers. However, managers maintain conviction in their software holdings, believing they possess competitive advantages beyond code including deterministic data, network effects, and regulatory moats that protect against AI disintermediation. The fund added positions in data center infrastructure company Forgent Power Solutions and increased holdings in undervalued software names like Dynatrace, Heartflow, and Waystar. Positive contributors included Advanced Energy Industries, which benefited from AI-driven data center demand, and several acquisition targets. Managers expect multiple catalysts including increased M&A activity, cyber-attacks highlighting security needs, and partnerships between legacy software companies and LLM providers to drive outperformance ahead.
Baron Discovery Fund focuses on competitively advantaged small-cap companies with strong management teams, maintaining conviction in software holdings despite AI disruption fears due to their protected characteristics including deterministic data, network effects, and regulatory moats.
Manager expects significant outperformance for years ahead in software holdings as multiple catalysts emerge to separate winners from losers. They believe current software valuations at 15-year lows present attractive opportunities for companies with sustainable competitive advantages.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 25 2026 | 2026 Q1 | AEIS, ARQT, DKNG, DT, HRTX, INTA, MASI, WAY | AI, cybersecurity, Data centers, healthcare, semiconductors, small cap, software, technology | - | Baron Discovery Fund underperformed due to AI disruption fears hitting software holdings despite strong earnings. Managers maintain conviction in software companies with competitive moats beyond code, adding to positions at attractive valuations. They expect catalysts including M&A activity and cybersecurity needs to drive outperformance as markets recognize value dispersion in software. |
| Jan 26 2026 | 2025 Q4 | ALKT, CWAN, CWST, DKNG, DT, ESTA, EXAS, FROG, GCI, GTLB, INDIE, LLYVA, LOAR, MRCY, PRMB, RGEN, S, SITM, TREX, VRNS, WAY | AI, defense, growth, healthcare, Quality, small caps, software |
EXAS ESTA CWAN WAY CAS FROG INDI VRNS LLYVA PRMB GLIBA CWST |
Baron Discovery Fund's systematic growth approach delivered 10.96% returns in 2025 despite market preference for low-quality momentum stocks. The fund maintains high-conviction positions in software, healthcare, and defense companies with competitive advantages. Management expects favorable 2026 conditions from declining inflation, AI infrastructure spending, and economic growth to benefit their anti-momentum, quality-focused strategy. |
| Oct 28 2025 | 2025 Q3 | AAON, AEIS, BIRK, BMI, CDNA, CYBR, DKNG, DT, EXAS, GTLS, INSP, KTOS, LLYVA, MEG, MRCY, PAR, PRMB, SPRY, WING, WYNN | cybersecurity, defense, earnings, growth, Quality, small cap, technology, water |
BIRK INSP WING KTOS BIRK PAR INSP WING KTOS |
Baron Discovery Fund underperformed in Q3 due to the worst Earnings Quality factor performance in 50 years, as speculative stocks dominated. The Fund avoided meme stocks and emerging tech sectors, instead focusing on defense spending beneficiaries and establishing positions in water distribution, footwear, and cybersecurity. Managers maintain conviction in quality-focused investing despite current market frothiness. |
| Jul 25 2025 | 2025 Q2 | ALKT, BASE, CW, CYBR, DAY, DKNG, DT, EXAS, GWRE, INSP, IRT, KTOS, LLYVA, MAC, MEG, MRCY, NOVT, PAR, RH, TEM, WYNN | AI, Cloud, cybersecurity, defense, growth, small caps, sports betting, technology |
KTOS MEG KARH CLWR INSP WYNN |
Baron Discovery Fund returned 14.76% in Q2 2025, outperforming the Russell 2000 Growth Index by 279 basis points. The fund navigated policy-driven volatility while benefiting from secular tailwinds in AI, defense, and cybersecurity. Small-cap growth stocks appear positioned for outperformance after extended underperformance, supported by attractive valuations and potential macroeconomic improvements from comprehensive policy reforms. |
| Mar 31 2025 | 2025 Q1 | AXON, CWAN, CYBR, DKNG, EXAS, GTLS, GWRE, INDI, INSP, KTOS, LLYVA, MASI, MEG, MRCY, NARI, PAR, RDDT, TEM, TTAN, WING | Biotechnology, defense, growth, Market Dislocation, small cap, tariffs, Value Investing |
EXAS INDI MEG WING KARM ACLX |
Baron Discovery Fund outperformed during Q1 2025 market decline driven by tariff concerns. The fund's investing in reverse strategy positions it to capitalize on market dislocations by purchasing high-quality, fast-growing companies at attractive valuations. Recent additions include Wingstop, defense contractor Karman Holdings, and biotech Arcellx. Small-cap growth valuations remain compelling with investor allocation at decade lows. |
| Dec 31 2024 | 2024 Q4 | AXON, CDNA, CWAN, CYBR, DAY, DKNG, EXAS, FND, GTLS, GWRE, IRT, KTOS, LLYVA, MAC, MEG, PAR, RDDT, S, TTAN, VRNS | contrarian, growth, REITs, small caps, software, technology, value |
CHT PAR MAC TTAN IRT BC.MI |
Baron Discovery Fund's contrarian approach delivered strong Q4 results with 6.20% returns, outperforming benchmarks through concentrated positions in AI-enabled public safety, energy transition infrastructure, and restaurant technology. New investments in mall REIT Macerich and trades software ServiceTitan reflect opportunistic value creation. Managers expect significant small-cap upside from anticipated policy tailwinds including deregulation and tax cuts. |
| Sep 30 2024 | 2024 Q3 | AEIS, AXON, BASE, CDNA, CWAN, CYBR, DKNG, EXAS, GTLS, GWRE, INDI, KTOS, LLYVA, MEG, NARI, PTECH, SIZE, TEM, TWFG, VCYT | growth, healthcare, rates, Rotation, small caps, technology, valuation |
CDNA AXON TEM TWFG NARI |
Baron Discovery Fund believes the three-year bear market in small-cap growth is ending. The Fed's rate cuts, small-cap valuations at 25-year discounts to large-cap, and investor under-allocation create a compelling setup. Key holdings like CareDx and Axon delivered strong performance, while new positions in TWFG and additions to Inari Medical position the fund for the expected rotation into small-cap growth. |
| Jul 31 2024 | 2024 Q2 | AEIS, AXON, BASE, CDXC, CHI, CYBR, DKNG, EXAS, FND, GTLB, GWRE, INSP, ITGR, KNSL, KTOS, MEG, NVMI, PAR, PCOR, SILK, SITE, STVN, TEM, TXRH | AI, Diagnostics, healthcare, small caps, technology, value, volatility | - | Baron Discovery Fund's Q2 underperformance reflects technical trading factors rather than fundamental deterioration. Managers see exceptional opportunities in small-cap growth stocks trading at historically low valuations, particularly AI-enabled software and diagnostics companies. With inflation softening and M&A activity increasing, they remain highly confident in long-term prospects despite continued near-term volatility. |
| Apr 15 2024 | 2024 Q1 | AEIS, ALGM, AXNX, AXON, CDNA, CYBR, DKNG, ENDV, ESTA, FND, GTLB, INTA, KNSL, MASI, MRCY, NARI, NVTS, RH, S, SITE | cybersecurity, growth, healthcare, semiconductors, small cap, technology, Valuations |
KNSL DKNG CYBR MASI INTA |
Baron Discovery Fund's Q1 underperformance was driven by an unprecedented single-stock impact from not owning Super Micro Computer. Small-cap growth stocks remain attractively valued versus large-caps and historically outperform coming out of market downturns. The portfolio is positioned to capitalize on the eventual transition from bear to bull market in small-cap growth. |
| Jan 30 2024 | 2023 Q4 | AAON, ACVA, AEIS, AXON, BASE, CYBR, DKNG, ESTA, EWCZ, FND, GTLB, GTLS, ICHR, KNSL, KTOS, MRAI, MRCY, REXR, S, VRNS | cybersecurity, defense, growth, HVAC, small caps, technology, value |
^FTSE GTLB VRNS AAON |
Baron Discovery Fund's 22.58% return in 2023 demonstrates the power of experiential judgment in small-cap investing. Strong cybersecurity holdings and new HVAC position AAON highlight the fund's ability to identify quality growth companies. With small-cap valuations attractive relative to large caps, 2024 should favor their fundamental analysis approach over algorithmic investing. |
| Sep 30 2023 | 2023 Q3 | AEIS, AXNX, AXON, BYD, CWAN, EWCZ, GTLB, GTLS, GWRE, INDI, KNSL, LLYVA, MEG, NVTS, PAR, REPG, REXR, RVNC, S, SILK, SITE, TXG | growth, healthcare, semiconductors, small caps, software, technology, value | - | Baron Discovery Fund outperformed in Q3 despite market headwinds, marking its 10-year anniversary with returns doubling the benchmark. The managers see compelling valuations amid peak pessimism and remain positioned for economic recovery. New positions in cybersecurity and life sciences reflect their fallen angel strategy, while strong software and insurance holdings drive performance. |
| Dec 31 2022 | 2022 Q4 | ALGM, AXON, CDNA, DH, FORG, GTLS, MEG, QLYS, RVNC, SMAR | - | - | |
| Sep 30 2022 | 2022 Q3 | AXON, CDNA, CWAN, DH, PING, RVNC, SFOR LN, SILK, SMAR, TXRH, WOOF | - | - | |
| Jun 30 2022 | 2022 Q2 | ALKT, ASGN, CDAY, CWAN, DAVA, DH, ESTA, GTLB, GWRE, MEG, PGNY, REXR, SAIL | - | - | |
| May 22 2022 | 2022 Q1 | ACC, AXNX, AXON, GTLS, JBGS, MRCY, PING, VLDX | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIManager discusses AI disruption impact on software companies, noting the SaaS-pocalypse where AI is changing the industry. However, they believe their software holdings have competitive advantages beyond code, including deterministic data, network effects, and regulatory moats that protect against AI disintermediation. |
Software Disruption LLM Competitive Advantages Deterministic Data |
SoftwareSoftware holdings were the primary detractor, contributing 4.36% of negative performance due to AI disruption fears. Manager maintains conviction in software companies with protected characteristics like deterministic data, network effects, and regulatory advantages, viewing current valuations as attractive despite near-term headwinds. |
SaaS Valuations Competitive Moats Enterprise Cybersecurity | |
Data CentersManager added new position in Forgent Power Solutions, a manufacturer of electrical distribution equipment for data centers. They see data center infrastructure build as creating supply/demand mismatch that Forgent is positioned to capitalize on with its manufacturing capacity and custom products. |
Infrastructure Power Equipment Manufacturing Supply Chain | |
CybersecurityManager highlights cybersecurity companies like SentinelOne as having advantages in seeing company data and parsing threats. They expect cyber-attacks based on LLM usage to create catalysts for cybersecurity software, noting recent LiteLLM attack as example of vulnerabilities. |
Endpoint Protection Network Security Threat Detection Enterprise Security | |
SemiconductorsSemiconductor exposure provided positive relative performance, particularly companies benefiting from AI secular growth narrative including semiconductor materials, equipment, and electronic instruments. Advanced Energy Industries performed well due to data center and semiconductor end market strength. |
AI Infrastructure Equipment Materials Power Management | |
| 2025 Q4 |
AIManager draws parallels between today's AI-driven market concentration and the 2014-15 oil collapse, warning that AI has become a macroeconomic assumption embedded in capital expenditure plans and valuations. Physical constraints like energy intensity and grid limitations complicate AI scalability assumptions. |
Artificial Intelligence Valuations Infrastructure Energy Scalability |
EnergyEnergy plays a critical role in AI infrastructure economics through data center power consumption. Rising electricity prices and grid constraints in data-center-heavy regions are compressing margins and extending deployment timelines, creating physical bottlenecks to AI scaling. |
Electricity Data Centers Grid Power Infrastructure | |
Small CapsThe portfolio consists of fundamentally strong small-cap businesses with resilient cash flows and improved competitive positions. Manager likes the current portfolio composition despite market preference for large-cap AI momentum over small-cap breadth. |
Small Cap Fundamentals Cash Flow Competitive Position | |
| 2025 Q3 |
Defense SpendingThe Fund benefits from a generational increase in defense spending amid heightened global conflicts. Defense companies like Kratos, Mercury Systems, and Karman Holdings are winning new contracts across multiple divisions and benefiting from the current administration's openness to smaller, agile defense contractors. The defense spending cycle appears to be in a generational upswing. |
Defense Contracts Spending Military Technology |
CybersecurityThe rising cybersecurity threat environment, proliferation of cloud and AI applications, and new regulatory requirements have made SASE a critical priority for large enterprises. Netskope is gaining market share due to its next-generation technology and unique architecture that provides granular control over modern applications including generative AI tools. |
SASE Cloud Security Data Protection Enterprise AI | |
WaterPrimo Brands benefits from tailwinds driving growth in water consumption as consumers become more health conscious and trade sugary soft drinks for water. The aging municipal water infrastructure in the U.S. is leading more people to seek out high-quality spring and purified water. |
Bottled Water Health Infrastructure Distribution Brands | |
| 2025 Q2 |
DefenseThe fund is positioned across multiple defense companies benefiting from increased funding and demand for advanced military technologies. Companies like Kratos Defense & Security Solutions and Karman Holdings are well positioned for accelerated multi-year growth in areas such as hypersonic technology, drone engines, missile defense, and space launch components. |
Defense Spending Hypersonics Drones Missiles Space |
AIApplied AI represents one of the powerful secular tailwinds benefiting portfolio companies. The fund holds positions in AI-powered observability and security platform businesses like Dynatrace that are capitalizing on the growing demand for AI-driven solutions. |
Artificial Intelligence Observability Security Analytics | |
CloudThe movement of application software to the cloud is identified as a key secular tailwind. Portfolio companies are benefiting from the ongoing digital transformation and cloud migration trends across enterprises. |
Cloud Migration SaaS Digital Transformation | |
CybersecurityCybersecurity is highlighted as one of the powerful secular tailwinds driving portfolio company growth. The fund maintains exposure to companies providing advanced security solutions in an increasingly digital world. |
Security Software Cyber Defense Data Protection | |
Sports BettingThe explosion in online sports betting represents a significant growth opportunity. DraftKings is positioned as a top contributor to performance, benefiting from the rapid expansion of legalized sports betting markets. |
Online Gambling Gaming Digital Entertainment | |
| 2025 Q1 |
DefenseThe fund has significant exposure to defense companies including Kratos Defense & Security Solutions and newly added Karman Holdings. These companies are positioned to benefit from growing defense spending on hypersonic missiles, space programs, and unmanned aircraft solutions. Karman specifically targets the fastest-growing segments of defense with 90% sole-sourced sales and proprietary IP-driven solutions. |
Defense Spending Hypersonics Space Missiles Drones |
BiotechnologyThe fund initiated a position in Arcellx, a biotechnology company developing next-generation CAR-T cell therapy for multiple myeloma treatment. The investment is based on the large proven market opportunity and Arcellx's safer therapy profile compared to existing treatments, with potential to capture meaningful market share in the $10-15 billion multiple myeloma CAR-T category. |
CAR-T Multiple Myeloma Gene Therapy Oncology Biotechnology | |
DiagnosticsExact Sciences Corporation, a major holding, provides cancer diagnostics through its flagship Cologuard colorectal cancer screening test. Despite competitive pressures from blood-based tests, the company maintains advantages in pre-cancer sensitivity and is developing its own blood-based tests to compete effectively in the large screening market. |
Cancer Screening Diagnostics Medical Devices Healthcare Genomics | |
SemiconductorsThe fund holds indie Semiconductor, which designs automotive semiconductors for advanced driver assistance systems and in-cabin features. Despite near-term headwinds from inventory corrections and automotive uncertainty, the company has a $7.1 billion strategic backlog and is positioned for outsized growth as its product mix shifts to higher-margin ADAS applications. |
Automotive Semiconductors ADAS Semiconductor Cycle Auto Parts Technology | |
RestaurantsThe fund initiated a position in Wingstop, a franchised limited-service restaurant company specializing in chicken wings. The investment thesis centers on the company's efficient franchise model, strong unit economics with 70%+ cash-on-cash returns for franchisees, and long-term growth potential to 10,000 global units from the current 2,500 locations. |
Franchising Quick Service Unit Growth Restaurants Consumer Discretionary | |
| 2024 Q4 |
AIAxon highlighted the 2025 launch of an AI bundle oriented around its innovative Draft One product which automates the process of report writing for public safety officers. This represents a significant expansion opportunity as Axon continues to find new areas of growth and pulls ahead of competition. |
Automation Public Safety Software Innovation Growth |
CybersecurityCyberArk Software represents the fund's largest position at 3.4% of net assets. The cybersecurity sector continues to be a core focus area for the fund's technology investments. |
Software Enterprise Security Technology | |
Commercial Real EstateThe fund initiated a position in Macerich, a REIT owning 43 high-quality malls. The fundamental backdrop for high-quality mall real estate remains favorable with robust tenant demand, shortage of desirable space, and enabling landlords to raise rents. A CEO transition provides turnaround opportunities. |
REITs Malls Retail Turnaround Management | |
Energy TransitionChart Industries serves long-duration secular growth markets including liquid natural gas, hydrogen, carbon capture, and water treatment. The company has record revenue, backlog, and margins with strong execution expected into 2025. |
LNG Hydrogen Carbon Capture Infrastructure Growth | |
SaaSServiceTitan operates as the leading business management software platform for trades, serving a $30 billion addressable market. PAR Technology continues building an all-in-one platform for enterprise restaurants with greater than 20% software revenue growth targets. |
Software Platforms Trades Restaurants Growth | |
| 2024 Q3 |
Small CapsThe fund believes the bear market in small-cap growth stocks that started in February 2021 is finally ending. Small-cap growth is trading at its largest discount relative to large cap in 25 years, with investors under-allocated to the asset class. The combination of lower interest rates, stronger economic growth, attractive valuations, and easier earnings comparisons creates a backdrop conducive for stronger small company fundamentals and valuation multiples. |
Small Cap Growth Valuation Rotation Outperformance Russell 2000 |
RatesLower interest rates are a positive for smaller growth companies as they increase the present value of future cash flows and expand valuation multiples. The Fed cut rates by 50 basis points in September, and lower rates are also a tailwind for the economy, creating an environment where portfolio companies can see accelerating revenue growth. |
Fed Interest Rates Monetary Policy Valuation Growth | |
Medical DevicesThe fund holds positions in medical device companies like CareDx, Inari Medical, and others focused on specialized treatments. CareDx benefited from CMS retiring a draft local coverage determination that had caused reimbursement issues. Inari Medical offers catheter-based devices for venous thromboembolism treatment with significant market opportunities in both PE and DVT markets worth about $6 billion total. |
Medical Devices Reimbursement VTE Healthcare Innovation | |
AIAxon Enterprise introduced Draft One software that leverages generative AI and body-worn camera audio to produce high-quality draft report narratives in seconds, freeing up 20-25% of an officer's day. This showcases the potential generative AI use cases in Axon's business and drove strong international bookings growth. |
Generative AI Software Automation Law Enforcement Innovation | |
| 2024 Q2 |
AIFund owns several AI-enabled companies including GitLab, SentinelOne, and Couchbase that adapt AI models to enhance their products. Also owns Nova Ltd., a semiconductor capital equipment company enabling AI chip manufacturing. Managers believe the market will broaden from AI hardware to adaptive AI investments. |
Software Semiconductors Machine Learning Enterprise Cybersecurity |
GLP1GLP-1 drugs have become the biggest class of therapeutics with expected 2024 sales of $50 billion. Fund has exposure through Stevanato Group which manufactures specialized components for injectable drugs, though near-term inventory issues have created headwinds. |
Pharmaceuticals Medical Devices Diabetes Weight Loss Injectable | |
DiagnosticsFund has increased exposure to diagnostics companies including Veracyte, CareDx, Exact Sciences, and new position Tempus AI. Managers see compressed valuations despite consistent execution, with Exact Sciences offering significant upside in colorectal cancer screening market. |
Cancer Testing Genomics Healthcare Screening | |
CybersecuritySentinelOne provides endpoint protection using AI to detect anomalous behavior and automate remediation. Despite beating revenue guidance, shares dropped on operating expense concerns but managers see significant upside potential with 25% revenue growth expected through 2028. |
Endpoint Protection AI Cloud Security Enterprise Automation | |
SemiconductorsNova Ltd. is a semiconductor capital equipment company focused on metrology for AI chip production. Astera Labs was sold after quick double due to AI hype exceeding reasonable valuation. Fund continues to look for small-cap AI hardware opportunities. |
Equipment Metrology AI Chips Manufacturing Hardware | |
| 2024 Q1 |
Small CapsFund focuses on small-cap growth stocks which remain in a three-plus year bear market while large-cap stocks reach all-time highs. Small-cap growth stocks have attractive valuations both on an absolute basis and relative to large-cap stocks, and typically show significant appreciation coming out of deep market downturns. |
Small Cap Growth Valuations Outperformance Recovery |
CybersecurityCyberArk Software delivered strong quarterly results with 36% annual recurring revenue growth and 20% free-cash-flow margins. The increasing frequency and severity of cyberattacks, new SEC regulatory requirements, and greater federal government emphasis on privilege controls are driving healthy demand. |
Identity Security Privileged Access Regulatory Government Growth | |
SemiconductorsMultiple semiconductor holdings including Navitas Semiconductor and SiTime Corporation faced near-term headwinds but maintain strong long-term positioning. Navitas highlighted design wins across mobile, data center, renewable energy, and vehicle electrification expected to ramp in 2024-2025. |
GaN Power Semiconductors Design Wins Electrification Data Center | |
Medical DevicesMasimo Corporation represents a special situation investment in vital sign monitoring equipment. The company is exploring separation of its consumer and healthcare businesses to unlock value in the under-appreciated healthcare business that produces recurring revenue from disposable sensors. |
Vital Signs Monitoring Healthcare Recurring Revenue Special Situation | |
Sports BettingDraftKings showed strong market share gains and improved outlook for future profitability. Market share capture has been driven by investment in innovative product offerings resulting in strong customer retention, and the company is well positioned to expand margins as the U.S. sports betting market grows. |
Online Sportsbook Market Share Customer Retention Profitability Expansion | |
| 2023 Q4 |
CybersecurityMultiple cybersecurity holdings performed strongly in Q4, with SentinelOne, GitLab, Varonis, and CyberArk all contributing positively. The managers see accelerating demand driven by AI adoption requiring data security, SEC disclosure requirements, and vendor consolidation favoring comprehensive platforms over point solutions. |
Endpoint Protection Cloud Security Data Security AI-enabled Consolidation |
AIAI is viewed as both an opportunity and democratizing force in markets. The managers believe AI will help investors but cannot replace experiential judgment in evaluating management teams. They see AI driving cybersecurity demand and enabling new product features like GitLab's generative AI coding tools. |
Artificial Intelligence Democratization Generative AI Automation | |
DefenseThe fund maintains 4.5% exposure to defense-oriented names and added to Mercury Systems position. The managers are convinced the new management team at Mercury has made meaningful progress in turnaround efforts and shares remain meaningfully undervalued. |
Defense Electronics Turnaround Undervalued | |
HVACNew position in AAON represents a high-quality manufacturer benefiting from decarbonization trends and ESG regulations. The company has superior energy-efficient products and is taking market share as price premiums compress. Management expects to double the investment over five years. |
Energy Efficiency Decarbonization Market Share Premium Products | |
Small CapsThe managers believe 2024 will be the year of small cap as relative valuations return to normalized levels, with small caps garnering bigger multiples than large caps. They see their experiential-based fundamental analysis being amply rewarded. |
Relative Valuation Multiples Outperformance | |
| 2023 Q3 |
CybersecurityThe fund initiated a position in SentinelOne, a cybersecurity vendor focused on endpoint protection using AI to detect threats. The company serves over 11,000 organizations and is gaining market share from legacy antivirus vendors who struggle with evolving threats. |
Endpoint Protection AI Detection Threat Environment Ransomware Security |
BiotechnologyThe fund added 10x Genomics, which sells innovative instruments for life sciences research including single-cell analysis platforms. The company has multiple growth drivers including new product cycles and expansion into biopharmaceuticals from basic research. |
Life Sciences Single Cell Genomics Research Tools Biopharmaceuticals | |
SemiconductorsNavitas Semiconductor, a leader in gallium nitride power semiconductors, faced near-term demand concerns but maintains strong design win momentum and opportunity pipeline growth across data center, solar, and electric vehicle applications. |
GaN Power Semiconductors Data Centers Electric Vehicles Solar | |
SoftwareMultiple software holdings including Clearwater Analytics (portfolio accounting software) and PAR Technology (restaurant SaaS) showed strong performance. These companies benefit from industry digitization trends and have efficient business models driving margin expansion. |
SaaS Portfolio Software Restaurant Technology Cloud Platforms Digitization |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | Fund Letters | Andrew Peck | EXAS | Exact Sciences Corp. | Health Care | Diagnostics & Research | Bull | NASDAQ | acquisition, Cancer Screening, cashflow, diagnostics, healthcare | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | ESTA | Establishment Labs Holdings Inc. | Health Care | Medical Devices | Bull | NASDAQ | Aesthetics, growth, innovation, market share, Medical devices | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | CWAN | Clearwater Analytics Holdings Inc. | Information Technology | Application Software | Bull | New York Stock Exchange | Fintech, Margins, private equity, recurring revenue, Software | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | WAY | Waystar Holding Corp. | Health Care | Health Care Technology | Bull | NASDAQ | AI, Automation, cashflow, Healthcare IT, Revenue cycle | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | CAS | Casella Waste Systems Inc. | Industrials | Waste Management | Bull | NASDAQ | consolidation, infrastructure, Margins, Pricing power, waste management | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | FROG | JFrog Ltd. | Information Technology | Application Software | Bull | NASDAQ | AI, cybersecurity, Devops, Free Cash Flow, Software Supply Chain | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | INDI | indie Semiconductor Inc. | Information Technology | Semiconductors | Bull | NASDAQ | Ad As, Auto-Semiconductors, Content, design wins, Electrification | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | VRNS | Varonis Systems Inc. | Information Technology | Security Software | Bull | NASDAQ | cybersecurity, Data Governance, recurring revenue, SaaS, Subscriptions | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | LLYVA | Liberty Live Group | Communication Services | Entertainment | Bull | NASDAQ | Live entertainment, NAV discount, Pricing power, Sponsorship, Ticketing | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | PRMB | Primo Brands Corp. | Consumer Staples | Household Products | Bull | New York Stock Exchange | Bottled Water, cashflow, consumer staples, Margins, recurring revenue | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | GLIBA | Liberty Broadband Corp. | Communication Services | Cable & Satellite | Bull | NASDAQ | broadband, cable, corporate actions, holding company, NAV discount | Login |
| Jan 26, 2026 | Fund Letters | Andrew Peck | CWST | Casella Waste Systems Inc. | Industrials | Waste Management | Bull | NASDAQ | consolidation, infrastructure, Margins, Pricing power, Waste bManagement | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | BIRK | Birkenstock Holding plc | Consumer Discretionary | Textiles, Apparel & Luxury Goods | Bull | NYSE | Brand Equity, direct-to-consumer, expansion, gross margins, vertical integration | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | INSP | Inspire Medical Systems, Inc. | Health Care | Health Care Equipment | Bear | NYSE | Competitive therapies, Execution, guidance, procedure volumes, Reimbursement | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | WING | Wingstop Inc. | Consumer Discretionary | Restaurants | Bull | NASDAQ | Commodity costs, Comps, Digital, Franchising, Unit economics | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | KTOS | Kratos Defense & Security Solutions, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | backlog, Defense spending, Hypersonics, operating leverage, Unmanned systems | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | BIRK | Birkenstock Holding plc | Consumer Discretionary | Textiles, Apparel & Luxury Goods | Bull | NYSE | Brand Equity, direct-to-consumer, expansion, gross margins, vertical integration | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | PAR | PAR Technology Corporation | Information Technology | Application Software | Bull | NYSE | ARR, Cloud pos, Enterprise wins, operating leverage, Restaurant technology | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | INSP | Inspire Medical Systems, Inc. | Health Care | Health Care Equipment | Bear | NYSE | Competitive therapies, Execution, guidance, procedure volumes, Reimbursement | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | WING | Wingstop Inc. | Consumer Discretionary | Restaurants | Bull | NASDAQ | Commodity costs, Comps, Digital, Franchising, Unit economics | Login |
| Oct 28, 2025 | Fund Letters | Andrew Peck | KTOS | Kratos Defense & Security Solutions, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | backlog, Defense spending, Hypersonics, operating leverage, Unmanned systems | Login |
| Jun 30, 2025 | Fund Letters | Baron Discovery Fund | KTOS | Kratos Defense & Security Solutions, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | Aerospace & Defense, Bull, defense technology, Drone Engines, government contracts, Hypersonic Technology, Microwave Electronics, Space Technology, Unmanned systems | Login |
| Jun 30, 2025 | Fund Letters | Baron Discovery Fund | MEG | Montrose Environmental Group, Inc. | Industrials | Environmental & Facilities Services | Bull | NYSE | attractive valuation, Bull, environmental services, Industrial Activity, organic growth, regulatory compliance, State Regulation, Testing and Monitoring | Login |
| Jun 30, 2025 | Fund Letters | Baron Discovery Fund | KARH | Karman Holdings Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | Bull, defense budget, Defense Systems, Exceptional Margins, Hypersonic Technology, Missile-Defense, Rocket Components, Space Launch | Login |
| Jun 30, 2025 | Fund Letters | Baron Discovery Fund | CLWR | Clearwater Analytics Holdings, Inc. | Information Technology | Application Software | Bull | NASDAQ | acquisition integration, Bull, Competitive advantages, EBITDA margins, High Growth, Portfolio Accounting, Reporting Software, SaaS | Login |
| Jun 30, 2025 | Fund Letters | Baron Discovery Fund | INSP | Inspire Medical Systems, Inc. | Health Care | Health Care Equipment | Bull | NYSE | Addressable market, Bull, Compelling Valuation, Hypoglossal Nerve Stimulation, long-term growth, market leadership, Medical Device, sleep apnea | Login |
| Jun 30, 2025 | Fund Letters | Baron Discovery Fund | WYNN | Wynn Resorts, Limited | Consumer Discretionary | Casinos & Gaming | Bull | NASDAQ | Bull, Casino Gaming, Chinese Tourism, Integrated Resort, Luxury Resort, Macau Recovery, Premium Positioning, UAE Expansion | Login |
| Mar 31, 2025 | Fund Letters | Baron Discovery Fund | EXAS | Exact Sciences Corporation | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | biotechnology, cancer diagnostics, Colorectal Cancer, healthcare, Medical devices, Screening Tests | Login |
| Mar 31, 2025 | Fund Letters | Baron Discovery Fund | INDI | indie Semiconductor, Inc. | Information Technology | Semiconductors | Bull | NASDAQ | Adas, Advanced Driver Assistance, Automotive Semiconductors, automotive technology, Radar, semiconductors, Vision Systems | Login |
| Mar 31, 2025 | Fund Letters | Baron Discovery Fund | MEG | Montrose Environmental Group, Inc. | Industrials | Environmental & Facilities Services | Bull | NYSE | Environmental consulting, environmental services, government contracts, regulatory compliance, Remediation, Value | Login |
| Mar 31, 2025 | Fund Letters | Baron Discovery Fund | WING | Wingstop Inc. | Consumer Discretionary | Restaurants | Bull | NASDAQ | asset-light, Chicken Wings, Franchise Restaurant, Franchising, Quick Service Restaurant, same-store sales, Unit growth | Login |
| Mar 31, 2025 | Fund Letters | Baron Discovery Fund | KARM | Karman Holdings Inc. | Industrials | Aerospace & Defense | Bull | NYSE | Aerospace, Defense Contractor, government contracts, Hypersonics, IPO, Missile-Defense, Proprietary technology, Space Launch | Login |
| Mar 31, 2025 | Fund Letters | Baron Discovery Fund | ACLX | Arcellx, Inc. | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, cancer treatment, CAR-T Therapy, cell therapy, Immunotherapy, Multiple Myeloma, Oncology, Partnership | Login |
| Dec 31, 2024 | Fund Letters | Baron Discovery Fund | CHT | Chart Industries, Inc. | Energy | Oil & Gas Equipment & Services | Bull | NASDAQ | carbon capture, EBITDA margins, energy transition, Hydrogen, Industrial Equipment, LNG, manufacturing, turnaround | Login |
| Dec 31, 2024 | Fund Letters | Baron Discovery Fund | PAR | PAR Technology Corporation | Information Technology | Application Software | Bull | NYSE | Acquisitions, EBITDA Profitability, Enterprise software, platform, Point of Sale, Restaurant technology, SaaS | Login |
| Dec 31, 2024 | Fund Letters | Baron Discovery Fund | MAC | The Macerich Company | Real Estate | Retail REITs | Bull | NYSE | CEO transition, Class A properties, Mall Real Estate, REIT, Supply-Demand Imbalance, turnaround, valuation discount | Login |
| Dec 31, 2024 | Fund Letters | Baron Discovery Fund | TTAN | ServiceTitan, Inc. | Information Technology | Application Software | Bull | NASDAQ | Field Service Management, margin expansion, market leader, network effects, Non-Discretionary, SaaS platform, Trades Software | Login |
| Dec 31, 2024 | Fund Letters | Baron Discovery Fund | IRT | Independence Realty Trust, Inc. | Real Estate | Residential REITs | Bull | NYSE | affordable housing, Development Projects, Multifamily REIT, supply constraints, valuation discount, Value-Add, Workforce Housing | Login |
| Dec 31, 2024 | Fund Letters | Baron Discovery Fund | BC.MI | Brunello Cucinelli S.p.A. | Consumer Discretionary | Apparel, Accessories & Luxury Goods | Bull | Borsa Italiana | Absolute Luxury, brand heritage, China expansion, Luxury goods, margin expansion, Pricing power, Recession proof | Login |
| Sep 30, 2024 | Fund Letters | Baron Discovery Fund | CDNA | CareDx, Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | CMS, diagnostics, Equity, healthcare, Medical Testing, Regulatory, Reimbursement, Transplant | Login |
| Sep 30, 2024 | Fund Letters | Baron Discovery Fund | AXON | Axon Enterprise, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | AI software, Body Cameras, Equity, international expansion, law enforcement, Public safety, SaaS, Tasers | Login |
| Sep 30, 2024 | Fund Letters | Baron Discovery Fund | TEM | Tempus AI, Inc. | Health Care | Life Sciences Tools & Services | Bull | NASDAQ | AI, cancer diagnostics, Clinical trials, Data licensing, Equity, Genomics, pharmaceuticals, Precision-medicine | Login |
| Sep 30, 2024 | Fund Letters | Baron Discovery Fund | TWFG | TWFG, Inc. | Financials | Insurance | Bull | NASDAQ | Capital-light, Equity, founder-led, Independent Agents, Insurance Broker, M&A, P&C insurance, platform | Login |
| Sep 30, 2024 | Fund Letters | Baron Discovery Fund | NARI | Inari Medical, Inc. | Health Care | Health Care Equipment & Supplies | Bull | NASDAQ | Clinical Studies, DVT, Equity, International, Market expansion, Medical devices, PE, Thromboembolism, Vascular | Login |
| Mar 31, 2024 | Fund Letters | Baron Discovery Fund | KNSL | Kinsale Capital Group, Inc. | Financials | Property & Casualty Insurance | Bull | NYSE | excess and surplus lines, financials, Insurance, premium growth, Property & Casualty, specialty insurance, underwriting | Login |
| Mar 31, 2024 | Fund Letters | Baron Discovery Fund | DKNG | DraftKings Inc. | Communication Services | Interactive Media & Services | Bull | NASDAQ | customer retention, Digital Entertainment, Free Cash Flow, market share, Online-Gaming, Sports betting, US gaming market | Login |
| Mar 31, 2024 | Fund Letters | Baron Discovery Fund | CYBR | CyberArk Software Ltd. | Information Technology | Systems Software | Bull | NASDAQ | Annual Recurring Revenue, cybersecurity, Enterprise software, Free Cash Flow, Identity Security, Privileged Access Management, SaaS | Login |
| Mar 31, 2024 | Fund Letters | Baron Discovery Fund | MASI | Masimo Corporation | Health Care | Health Care Equipment | Bull | NASDAQ | business separation, Healthcare Equipment, medical technology, Patent Litigation, razor-and-blade model, Special Situation, Vital Sign Monitoring | Login |
| Mar 31, 2024 | Fund Letters | Baron Discovery Fund | INTA | Intapp, Inc. | Information Technology | Application Software | Bull | NASDAQ | Annual Recurring Revenue, Cloud software, Enterprise software, Legal Technology, Private Equity Software, Professional Services Software, SaaS | Login |
| Dec 31, 2023 | Fund Letters | Baron Discovery Fund | ^FTSE | SentinelOne, Inc. | Information Technology | Systems Software | Bull | NYSE | AI-enabled, cloud security, cybersecurity, endpoint protection, growth, SaaS, technology | Login |
| Dec 31, 2023 | Fund Letters | Baron Discovery Fund | GTLB | GitLab Inc. | Information Technology | Application Software | Bull | NASDAQ | AI, Devops, enterprise, platform, SaaS, Software Development, technology | Login |
| Dec 31, 2023 | Fund Letters | Baron Discovery Fund | VRNS | Varonis Systems, Inc. | Information Technology | Systems Software | Bull | NASDAQ | AI, cybersecurity, Data Security, enterprise, Regulatory, SaaS, technology | Login |
| Dec 31, 2023 | Fund Letters | Baron Discovery Fund | AAON | AAON, Inc. | Industrials | Building Products | Bull | NASDAQ | Decarbonization, energy efficiency, ESG, HVAC, Industrials, margin expansion, market share | Login |
| TICKER | COMMENTARY |
|---|---|
| AEIS | Advanced Energy Industries, Inc. is a designer and manufacturer of products used to transform, refine, and modify electrical power for use in semiconductor, industrial, medical, data center, and telecommunications end markets. Advanced Energy's stock rose during the quarter as earnings and guidance were better than expected and as the market began to appreciate the strength that the company would see in both its data center and semiconductor end markets. |
| MASI | Masimo Corporation is a medical device company that manufactures and sells a variety of non-invasive patient monitoring technologies, including its well-known pulse oximeters used to measure blood oxygen levels. Shares outperformed for the quarter after Danaher Corporation announced that it would acquire Masimo at a 38% premium. |
| ARQT | Arcellx, Inc. is a biotechnology company which uses CAR-T technology (modifies a patient's own immune cells to recognize and destroy cancer cells) to treat multiple myeloma. It is due to be acquired by Gilead Sciences Inc. in June (around which time we expect that Arcellx will receive FDA approval for its drug called Antio-cel). |
| INTA | Intapp, Inc., a vertical software platform serving private equity, legal, and consulting firms, detracted from performance this quarter. The drawdown was driven by a sector-wide AI disruption narrative that hit legal-adjacent software stocks particularly hard, with Intapp declining sharply through mid-February after Anthropic announced new legal tools. We sold our investment in the quarter as we believe that our other software holdings have better overall competitive advantages. |
| DKNG | DraftKings Inc. is the leading U.S. digital sports betting and iCasino operator. The stock declined as investors grappled with a guidance range that implied handle (amount bet) deceleration, elevated prediction markets investments to compete with firms like Kalshi and Polymarkets, and lingering debate around structural hold (the percentage of overage profit per bet) sustainability. |
| DT | We added to our position in Dynatrace, Inc., a provider of observability software. For the reasons we laid out above we believe that this is a great deterministic data-oriented company, benefiting from significant competitive advantages. However, it is trading at a rock-bottom multiple (13 times free cash flow, with that metric is likely to grow in the mid-teens for the next few years). |
| WAY | Finally, we added to Waystar Holding Corp., which like Heartflow has been lumped into the AI software losers bucket. Waystar is a provider of revenue cycle management software to health care providers. The company has an AI driven, end-to-end suite of solutions that saves clients massive amounts of working capital costs by getting claims submitted quickly and correctly, and by automating insurance appeals when necessary. At under 11 times adjusted cash flow, but growing cash flow in the low teens, we believe the company is competitively advantaged and very cheap. |
| HRTX | We also added to Heartflow, Inc., whose software analyzes CT scans of a patient's coronary arteries done with contrast, and shows calcification, plaque buildup, and blood flow quality in a three-dimensional model. It is hard to understand how Heartflow would be easily disintermediated, given the customer trust it has built up, and its FDA approved software based on significant clinical trials and millions of real-world CT scan analyses. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||